# Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer

> **NCT00527930** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 87 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** TS-1 and Eloxatin

## Key facts

- **NCT ID:** NCT00527930
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2013-10-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00527930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00527930, "Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00527930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*